Dicerna Pharmaceuticals Inc. buy stratec
Start price
06.11.18
/
50%
€13.16
Target price
04.11.21
€28.00
Performance (%)
45.78%
End price
05.11.21
€19.19
Summary
This prediction ended on 05.11.21 with a price of €19.19. The BUY prediction by stratec for Dicerna Pharmaceuticals Inc. saw massive gains of 45.78%. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Dicerna Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | -0.372% | 5.236% | 16.908% | 16.016% |
| iShares Nasdaq 100 | -1.950% | 1.680% | 19.890% | 31.832% |
| iShares Nikkei 225® | -1.690% | 7.286% | 12.202% | 3.400% |
| iShares S&P 500 | -0.399% | 2.379% | 20.975% | 36.224% |
Comments by stratec for this prediction
In the thread Dicerna Pharmaceuticals Inc. diskutieren
stratec stimmt der Outperform-Einschätzung der institutionellen Analysten zu
Dicerna Pharmaceuticals upgraded to Buy with a $21 (62% upside) price target at B. Riley FBR citing upside for HBV candidate DCR-HBVS and recent financing and partnership activities with Alexion Pharmaceuticals and Eli Lilly.
Kursziel geändert auf 26,0
Kursziel geändert auf 28,0
In the thread Trading Dicerna Pharmaceuticals Inc.
Die von stratec gewählte maximale Laufzeit wurde überschritten